SCL - Stepan Company

NYSE - NYSE Delayed Price. Currency in USD
90.27
-0.30 (-0.33%)
At close: 4:02PM EDT
Stock chart is not supported by your current browser
Previous Close 90.57
Open 91.00
Bid 90.47 x 900
Ask 90.67 x 800
Day's Range 89.94 - 91.39
52 Week Range 68.09 - 95.32
Volume 73,630
Avg. Volume 83,811
Market Cap 2.041B
Beta (3Y Monthly) 0.95
PE Ratio (TTM) 18.69
EPS (TTM) 4.83
Earnings Date Apr 30, 2019
Forward Dividend & Yield 1.00 (1.14%)
Ex-Dividend Date 2019-03-01
1y Target Est 101.50
Trade prices are not sourced from all markets
  • Is Stepan Company's (NYSE:SCL) Liquidity Good Enough?
    Simply Wall St. 21 hours ago

    Is Stepan Company's (NYSE:SCL) Liquidity Good Enough?

    Mid-caps stocks, like Stepan Company (NYSE:SCL) with a market capitalization of US$2.0b, aren’t the focus of most investors who prefer to direct their investments towards either large-cap or small-cap stocks. However, history shows...

  • Markit 16 days ago

    See what the IHS Markit Score report has to say about Stepan Co.

    Stepan Co NYSE:SCLView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output in this company's sector is contracting Bearish sentimentShort interest | PositiveShort interest is extremely low for SCL with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting SCL. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $928 million over the last one-month into ETFs that hold SCL are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers’ Index (PMI) data, output in the Basic Materialsis falling. The rate of decline is significant relative to the trend shown over the past year. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Does Stepan Company's (NYSE:SCL) Past Performance Indicate A Stronger Future?
    Simply Wall St. 16 days ago

    Does Stepan Company's (NYSE:SCL) Past Performance Indicate A Stronger Future?

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! When Stepan Company (NYSE:SCL) released its most recent earnings update (31 December 2018), I wanted to understand how these...

  • PR Newswire 16 days ago

    Stepan to Announce First Quarter 2019 Results on April 30, 2019

    NORTHFIELD, Ill., April 2, 2019 /PRNewswire/ -- Stepan Company (SCL) will issue its first quarter 2019 earnings results on Tuesday, April 30, 2019 at approximately 7:00 am ET (6:00 am CT). The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day, at 8:00 am ET (7:00 am CT). The call will be hosted by F. Quinn Stepan, Jr., Chairman, President and Chief Executive Officer, and Luis E. Rojo, Vice President and Chief Financial Officer.

  • Have Insiders Been Selling Stepan Company (NYSE:SCL) Shares?
    Simply Wall St. last month

    Have Insiders Been Selling Stepan Company (NYSE:SCL) Shares?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On the other hand, we'd be remiss not to mentionRead More...

  • Thomson Reuters StreetEvents last month

    Edited Transcript of SCL earnings conference call or presentation 21-Feb-19 3:00pm GMT

    Q4 2018 Stepan Co Earnings Call

  • Should You Be Holding Stepan Company (NYSE:SCL)?
    Simply Wall St. 2 months ago

    Should You Be Holding Stepan Company (NYSE:SCL)?

    Stepan Company (NYSE:SCL) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In the caseRead More...

  • GuruFocus.com 2 months ago

    Stepan Co (SCL) Files 10-K for the Fiscal Year Ended on December 31, 2018

    Stepan Co, along with its subsidiaries produces specialty and intermediate chemicals, which are sold to other manufacturers and are used in end products. The dividend yield of Stepan Co stocks is 1.00%. Stepan Co had annual average EBITDA growth of 7.90% over the past ten years.

  • Stepan Co (SCL) Q4 2018 Earnings Conference Call Transcript
    Motley Fool 2 months ago

    Stepan Co (SCL) Q4 2018 Earnings Conference Call Transcript

    SCL earnings call for the period ending December 31, 2018.

  • Stepan Co. (SCL) Surpasses Q4 Earnings Estimates
    Zacks 2 months ago

    Stepan Co. (SCL) Surpasses Q4 Earnings Estimates

    Stepan Co. (SCL) delivered earnings and revenue surprises of 36.00% and -3.50%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press 2 months ago

    Stepan Co.: 4Q Earnings Snapshot

    On a per-share basis, the Northfield, Illinois-based company said it had profit of $1.16. Earnings, adjusted for non-recurring gains, came to $1.02 per share. The results topped Wall Street expectations. ...

  • PR Newswire 2 months ago

    Stepan Declares Quarterly Dividend

    On February 20, 2019, the Board of Directors of Stepan Company declared a quarterly cash dividend on the Company's common stock of $0.25 per share.  The dividend is payable on March 15, 2019, to common stockholders of record on March 4, 2019.  The Company increased its quarterly cash dividend in the fourth quarter of 2018 by $0.025 per share, marking the 51st consecutive year that the Company has increased its cash dividend to stockholders. Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries.  Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning compounds and in agricultural and oilfield solutions.  The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries.

  • PR Newswire 2 months ago

    Stepan Reports Fourth Quarter and Record Full Year 2018 Results

    NORTHFIELD, Ill. , Feb. 21, 2019 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported: Fourth Quarter Highlights Reported net income was $26.9 million , or $1.16 per diluted share versus $9.9 million ...

  • Who are Procter & Gamble's main competitors?
    Investopedia 2 months ago

    Who are Procter & Gamble's main competitors?

    Learn about Procter & Gamble's major competitors in each of its revenue segments, including fabric care and home care, and beauty, hair and personal care.

  • Earnings Preview: Stepan Co. (SCL) Q4 Earnings Expected to Decline
    Zacks 2 months ago

    Earnings Preview: Stepan Co. (SCL) Q4 Earnings Expected to Decline

    Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Is Stepan Company (NYSE:SCL) Potentially Undervalued?
    Simply Wall St. 2 months ago

    Is Stepan Company (NYSE:SCL) Potentially Undervalued?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Stepan Company (NYSE:SCL), which is in theRead More...

  • Is Stepan Company (NYSE:SCL) Spending Too Much Money?
    Simply Wall St. 3 months ago

    Is Stepan Company (NYSE:SCL) Spending Too Much Money?

    Two important questions to ask before you buy Stepan Company (NYSE:SCL) is, how it makes money and how it spends its cash. What is left after investment, determines the value Read More...

  • PR Newswire 3 months ago

    Stepan to Announce Fourth Quarter and Full Year 2018 Results on February 21, 2019

    NORTHFIELD, Ill., Jan. 22, 2019 /PRNewswire/ -- Stepan Company (SCL) will issue its fourth quarter and full year 2018 earnings results on Thursday, February 21, 2019 at approximately 7:00 am ET (6:00 am CT). The Company will hold its conference call to discuss and answer questions about its financial and operational performance on the same day, at 10:00 am ET (9:00 am CT). The call will be hosted by F. Quinn Stepan, Jr., Chairman, President and Chief Executive Officer, and Luis E. Rojo, Vice President and Chief Financial Officer.

  • Does Stepan Company’s (NYSE:SCL) P/E Ratio Signal A Buying Opportunity?
    Simply Wall St. 3 months ago

    Does Stepan Company’s (NYSE:SCL) P/E Ratio Signal A Buying Opportunity?

    This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll show how you can use Stepan Company's (NYSE:SCL) P/E ratio Read More...

  • Can Stepan Company (NYSE:SCL) Improve Its Returns?
    Simply Wall St. 4 months ago

    Can Stepan Company (NYSE:SCL) Improve Its Returns?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...

  • What Type Of Shareholder Owns Stepan Company’s (NYSE:SCL)?
    Simply Wall St. 4 months ago

    What Type Of Shareholder Owns Stepan Company’s (NYSE:SCL)?

    The big shareholder groups in Stepan Company (NYSE:SCL) have power over the company. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable Read More...

  • GlobeNewswire 5 months ago

    New Research Coverage Highlights Immunomedics, Surmodics, PDF Solutions, Stepan, Express Scripts Holding, and BioCryst Pharmaceuticals — Consolidated Revenues, Company Growth, and Expectations for 2018

    NEW YORK, Nov. 27, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.